Eneraqua Technolgs. - Resignation of Nominated Adviser and Joint Broker

Eneraqua Technologies

21/07/2025 07:00

RNS Number : 7512R

Eneraqua Technologies PLC

21 July 2025

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EU (WITHDRAWAL) ACT 2018. 

21 July 2025

 

Eneraqua Technologies plc

("Eneraqua", the "Company" or the "Group")

Resignation of Nominated Adviser and Joint Broker

Eneraqua Technologies plc ("Eneraqua Technologies " or the "Company") announces that Panmure Liberum Limited ("Panmure Liberum") has resigned with immediate effect as the Company's Nominated Adviser and Joint Broker under the terms and conditions of its Nominated Adviser and Joint Broker Agreement.

Accordingly, the Company's ordinary shares will remain suspended from trading on AIM, inter alia, pursuant to AIM Rule 1, pending the appointment of a replacement nominated adviser.

If the Company fails to appoint a replacement nominated adviser within one month of today's date, admission of the Company's shares to trading on AIM will be cancelled.

 

For further information please contact:
Eneraqua Technologies plc
Mitesh Dhanak, Chief Executive Officer
John Samuel, Chief Financial Officer
Via Alma
Singer Capital Markets(Joint Broker)
Asha Chotai
Tel: 020 7496 3000

 Alma Strategic Communication (Financial PR)
Justine James
Andy Bryant
Will Ellis Hancock
Tel: 020 3405 0205
eneraqua@almastrategic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
MSCGPUGAMUPAGMR